These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 30878325)

  • 1. Patients' Motivation for Surgical Versus Medical Abortion.
    Murray ME; Casson M; Pudwell J; Waddington A
    J Obstet Gynaecol Can; 2019 Sep; 41(9):1325-1329. PubMed ID: 30878325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring Canadian women's knowledge of and interest in mifepristone: results from a national qualitative study with abortion patients.
    Vogel KI; LaRoche KJ; El-Haddad J; Chaumont A; Foster AM
    Contraception; 2016 Aug; 94(2):137-42. PubMed ID: 27125893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immediate versus delayed insertion of an etonogestrel releasing implant at medical abortion-a randomized controlled equivalence trial.
    Hognert H; Kopp Kallner H; Cameron S; Nyrelli C; Jawad I; Heller R; Aronsson A; Lindh I; Benson L; Gemzell-Danielsson K
    Hum Reprod; 2016 Nov; 31(11):2484-2490. PubMed ID: 27664217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards safe abortion access: an exploratory study of medical abortion in Cambodia.
    Petitet PH; Ith L; Cockroft M; Delvaux T
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):47-55. PubMed ID: 25702068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The efficacy and acceptability of mifepristone medical abortion with home administration misoprostol provided by private providers linked with the hospital: a prospective study of 433 patients].
    Faucher P; Baunot N; Madelenat P
    Gynecol Obstet Fertil; 2005 Apr; 33(4):220-7. PubMed ID: 15894206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship of contextual factors to women's perceptions of medical abortion.
    Harvey SM; Beckman LJ; Roberts Branch M
    Health Care Women Int; 2002; 23(6-7):654-65. PubMed ID: 12418986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Could implementation of mifepristone address Canada's urban-rural abortion access disparity: a mixed-methods implementation study protocol.
    Norman WV; Munro S; Brooks M; Devane C; Guilbert E; Renner R; Kendall T; Soon JA; Waddington A; Wagner MS; Dunn S
    BMJ Open; 2019 Apr; 9(4):e028443. PubMed ID: 31005943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Can mifepristone medication abortion be successfully integrated into medical practices that do not offer surgical abortion?
    Leeman L; Asaria S; Espey E; Ogburn J; Gopman S; Barnett S
    Contraception; 2007 Aug; 76(2):96-100. PubMed ID: 17656177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Understanding women's experiences with medical abortion: In-depth interviews with women in two Indian clinics.
    Ganatra B; Kalyanwala S; Elul B; Coyaji K; Tewari S
    Glob Public Health; 2010; 5(4):335-47. PubMed ID: 19431005
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective study of home use of mifepristone and misoprostol for medical abortion up to 10weeks of pregnancy in Kazakhstan.
    Platais I; Tsereteli T; Grebennikova G; Lotarevich T; Winikoff B
    Int J Gynaecol Obstet; 2016 Sep; 134(3):268-71. PubMed ID: 27352735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding access to medical abortion: challenges and opportunities.
    Ganatra B; Guest P; Berer M
    Reprod Health Matters; 2015 Feb; 22(44 Suppl 1):1-3. PubMed ID: 25702063
    [No Abstract]   [Full Text] [Related]  

  • 12. Early abortion in Ontario: options and costs.
    Limacher JJ; Daniel I; Isaacksz S; Payne GJ; Dunn S; Coyte PC; Laporte A
    J Obstet Gynaecol Can; 2006 Feb; 28(2):142-8. PubMed ID: 16643717
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acceptability of suction curettage and mifepristone abortion in the United States: a prospective comparison study.
    Jensen JT; Harvey SM; Beckman LJ
    Am J Obstet Gynecol; 2000 Jun; 182(6):1292-9. PubMed ID: 10871441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of medical abortion with surgical vacuum aspiration: women's preferences and acceptability of treatment.
    Henshaw RC; Naji SA; Russell IT; Templeton AA
    BMJ; 1993 Sep; 307(6906):714-7. PubMed ID: 8401094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia.
    Tsereteli T; Chong E; Louie K; Bokhua Z; Winikoff B
    Eur J Contracept Reprod Health Care; 2016 Oct; 21(5):367-71. PubMed ID: 27449873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical versus surgical abortion: a survey of knowledge and attitudes among abortion clinic patients.
    Virgo KS; Carr TR; Hile A; Virgo JM; Sullivan GM; Kaikati JG
    Womens Health Issues; 1999; 9(3):143-54. PubMed ID: 10340020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Knowledge and perceptions of medical abortion among potential users.
    Harvey SM; Beckman LJ; Castle MA; Coeytaux F
    Fam Plann Perspect; 1995; 27(5):203-7. PubMed ID: 9104607
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological outcomes of medical versus surgical elective first trimester abortion.
    Crandell L
    Nurs Womens Health; 2012; 16(4):296-307. PubMed ID: 22900806
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are US health professionals likely to prescribe mifepristone or methotrexate?
    Koenig JD; Tapias MP; Hoff T; Stewart FH
    J Am Med Womens Assoc (1972); 2000; 55(3 Suppl):155-60. PubMed ID: 10846327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing office and telephone follow-up after medical abortion.
    Chen MJ; Rounds KM; Creinin MD; Cansino C; Hou MY
    Contraception; 2016 Aug; 94(2):122-6. PubMed ID: 27101901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.